hydroxychloroquine has been researched along with Hepatic Failure in 3 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Excerpt | Relevance | Reference |
---|---|---|
"Chloroquine and hydroxychloroquine are quinoline derivatives used to treat malaria." | 5.05 | Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection. ( Cook, J; Joshi, A; Nicol, MR; Rizk, ML; Sabato, PE; Savic, RM; Wesche, D; Zheng, JH, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Heinz, N | 1 |
Griesemer, A | 1 |
Kinney, J | 1 |
Vittorio, J | 1 |
Lagana, SM | 1 |
Goldner, D | 1 |
Velasco, M | 1 |
Kato, T | 1 |
Lobritto, S | 1 |
Martinez, M | 1 |
Nicol, MR | 1 |
Joshi, A | 1 |
Rizk, ML | 1 |
Sabato, PE | 1 |
Savic, RM | 1 |
Wesche, D | 1 |
Zheng, JH | 1 |
Cook, J | 1 |
Dale, M | 1 |
Sogawa, H | 1 |
Seyedsaadat, SM | 1 |
Wolf, DC | 1 |
Bodin, R | 1 |
Partiula, B | 1 |
Nog, R | 1 |
Latifi, R | 1 |
John, D | 1 |
Veillette, G | 1 |
Diflo, T | 1 |
Nishida, S | 1 |
1 review available for hydroxychloroquine and Hepatic Failure
Article | Year |
---|---|
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 Infection.
Topics: Age Factors; Aging; Antiviral Agents; Chloroquine; Clinical Trials, Phase II as Topic; Clinical Tria | 2020 |
2 other studies available for hydroxychloroquine and Hepatic Failure
Article | Year |
---|---|
A case of an Infant with SARS-CoV-2 hepatitis early after liver transplantation.
Topics: Biliary Atresia; COVID-19; COVID-19 Testing; Female; Graft Rejection; Humans; Hydroxychloroquine; Im | 2020 |
Successful Management of COVID-19 Infection in 2 Early Post-Liver Transplant Recipients.
Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-1 | 2021 |